Zai Lab Limited (HKG:9688)
26.90
+0.30 (1.13%)
Mar 3, 2025, 4:08 PM HKT
Zai Lab Revenue
In the year 2024, Zai Lab had annual revenue of $398.99M USD with 49.59% growth. Zai Lab had revenue of $109.07M in the quarter ending December 31, 2024, with 65.68% growth.
Revenue
$398.99M
Revenue Growth
+49.59%
P/S Ratio
n/a
Revenue / Employee
$183.44K
Employees
2,175
Market Cap
28.98B HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 398.99M | 132.27M | 49.59% |
Dec 31, 2023 | 266.72M | 51.68M | 24.03% |
Dec 31, 2022 | 215.04M | 70.73M | 49.01% |
Dec 31, 2021 | 144.31M | 95.35M | 194.77% |
Dec 31, 2020 | 48.96M | 35.97M | 277.04% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 29.60B |
JD Health International | 58.84B |
Hansoh Pharmaceutical Group Company | 13.00B |
WuXi Biologics | 18.39B |
Alibaba Health Information Technology | 31.39B |
Innovent Biologics | 8.01B |
Akeso | 2.01B |
Sinopharm Group | 634.32B |
Zai Lab News
- 5 days ago - Zai Lab Q4 2024 Earnings Preview - Seeking Alpha
- 17 days ago - Janus Henderson Group PLC Significantly Increases Stake in Zai Lab Ltd - GuruFocus
- 21 days ago - Wellington Management Group LLP's Strategic Acquisition in Zai Lab Ltd - GuruFocus
- 4 weeks ago - Zai Lab to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Recent Corporate Updates on February 27, 2025 - Business Wire
- 5 weeks ago - Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatment of Small Cell Lung Cancer (SCLC) - Business Wire
- 6 weeks ago - Chinese regulators accept Zai Lab application for KarXT - Seeking Alpha
- 6 weeks ago - Zai Lab Ltd (ZLAB) Announces NDA Acceptance for KarXT in China - GuruFocus
- 6 weeks ago - Zai Lab Announces Acceptance of New Drug Application for KarXT for the Treatment of Schizophrenia - Business Wire